Schwab, KarimaFrahm, SilkeHorsley, DavidRickard, Janet EMelis, ValeriaGoatman, Elizabeth AMagbagbeolu, MandyDouglas, MoragLeith, Michael GBaddeley, Thomas C.Storey, John M DRiedel, GernotWischik, Claude MHarrington, Charles RTheuring, Franz2018-02-012018-02-012018-01-10Schwab, K, Frahm, S, Horsley, D, Rickard, J E, Melis, V, Goatman, E A, Magbagbeolu, M, Douglas, M, Leith, M G, Baddeley, T C, Storey, J M D, Riedel, G, Wischik, C M, Harrington, C R & Theuring, F 2018, 'A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy', Frontiers in Molecular Neuroscience, vol. 10, 447. https://doi.org/10.3389/fnmol.2017.004471662-5099PubMedCentral: PMC5767730ORCID: /0000-0002-5261-5467/work/73579148ORCID: /0000-0001-7063-7136/work/96652493ORCID: /0000-0003-2250-3920/work/47672902http://hdl.handle.net/2164/9976The authors acknowledge Heide Lueck for excellent technical assistance and for maintenance of animals. AMS Biotechnology generated monoclonal antibodies from recombinant α-Syn prepared by JR.156999156engSDG 3 - Good Health and Well-beingaggregation inhibitorsynucleinopathyleucomethylthioniniummouse modelParkinson’s diseaseα-SynucleinQD ChemistryQDJournal article10.3389/fnmol.2017.0044710